A poster commonly referred to as BDZ posted a link to a tweet put out by Resverlogix's corporate twitter account.
Diabetes is an increasing global epidemic and a known risk factor of CVD #ChangingDiabetes #SaveLives https://t.co/mEmLLpXryL
— Resverlogix Corp. (@Resverlogix_RVX) November 7, 2016
That actually is a "retweet" of a tweet with an embedded video by the company Novo Nordisk, a European Copenhagen based Pharma company.
It has me thinking there's at least a 50/50 chance that the partner/licensing deal investors have been told is coming...that it may very well be with Novo which trades on the NYSE under the symbol NOV.
If you want to taste the fruit, you have to go out on a limb. But if you wait for the herd to move out on the limb....the branch tends to snap.
North Bay Resources Commences Operations at Bishop Gold Mill, Inyo County, California; Engages Sabean Group Management Consulting • NBRI • Sep 25, 2024 9:15 AM
CEO David B. Dorwart Anticipates a Bright Future at Good Gaming Inc. Through His Most Recent Shareholder Update • GMER • Sep 25, 2024 8:30 AM
Cannabix Technologies and Omega Laboratories Inc. Advance Marijuana Breathalyzer Technology - Dr. Bruce Goldberger to Present at Society of Forensic Toxicologists Conference • BLOZF • Sep 24, 2024 8:50 AM
Integrated Ventures, Inc Announces Strategic Partnership For GLP-1 (Semaglutide) Procurement Through MedWell USA, LLC. • INTV • Sep 24, 2024 8:45 AM
Avant Technologies Accelerates Creation of AI-Powered Platform to Revolutionize Patient Care • AVAI • Sep 24, 2024 8:00 AM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM